Search results for "Anticoagulation"
Switching to newer oral anticoagulant didn't benefit frail older patients with afib
A randomized trial that switched some frail atrial fibrillation patients from vitamin K antagonists (VKAs) to non-vitamin K oral anticoagulants found that such patients had more bleeding and no decrease in thromboembolic events compared to those who stayed on a VKA.
https://acphospitalist.acponline.org/archives/2023/09/06/switching-to-newer-oral-anticoagulant-didnt-benefit-frail-older-patients-with-afib.htm
6 Sep 2023
Early anticoagulation appears safe after acute ischemic stroke in patients with afib
The AREST trial, which ended early due to changes in national guidelines, found statistically similar but numerically lower rates of the primary study outcome (fatal stroke, recurrent ischemic stroke, or transient ischemic attack) in those who received anticoagulation early with apixaban versus later with warfarin.
https://acphospitalist.acponline.org/weekly/archives/2021/03/03/5.htm
3 Mar 2021
Decision pathway addresses bleeding in patients on oral anticoagulants
The guidance from the American College of Cardiology covers management of major and minor bleeding in patients treated with direct-acting oral anticoagulants or vitamin K antagonists for any indication.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/4.htm
22 Jul 2020
FDA provides info on stimulant shortage
Also, a sterilizer for 3D-printed medical devices, a drug for postpartum depression, and an RSV vaccine for pregnant patients were approved, among other recent FDA actions.
https://acphospitalist.acponline.org/archives/2023/08/30/fda-provides-info-on-stimulant-shortage.htm
30 Aug 2023
tPA bolus within 48 hours of DOAC use not associated with increased risk for intracerebral hemorrhage vs. warfarin or no anticoagulation
A systematic review and meta-analysis compared the rate of symptomatic intracerebral hemorrhage in stroke patients pretreated with a direct oral anticoagulant (DOAC) versus those without prior anticoagulation and those on warfarin with an international normalized ratio below 1.7.
https://acphospitalist.acponline.org/weekly/archives/2020/01/08/3.htm
8 Jan 2020
October 2016
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2016/10/
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021
February 2016
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2016/02/
COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects
The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021
September 2016
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2016/09/